----

**EXHIBIT 31.2**

****

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO THE SECURITIES EXCHANGE ACT OF1934,**

**RULES 13a-14 AND 15d-14**

**AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF2002**

****

In connection with the Annual Report of PeptideTechnologies, Inc. (the "Company") on Form 10-K for the fiscal year ended March 31, 2019 as filed with the Securitiesand Exchange Commission on the date hereof (the "Report"), I, Irene Getty, Chief Financial Officer of the Company,certify, pursuant to Rules 13a-14 and 15-d14 of the Securities Exchange Act of 1934 (the "Exchange Act"), as adoptedpursuant to Section 302 of the Sarbanes-Oxley Act of 2002, that:

 

I have reviewed this annual   report on Form 10-K of PeptideTechnologies, Inc.

 

| 1. | Based on my knowledge, thisreport does not contain   any untrue statement of a material fact or omit to state a material fact   necessary to makethe statements made, in light of the circumstances under   which such statements were made, not misleading with respectto the period   covered by this report; |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

| 2. | Based on my knowledge, thefinancial statements, and   other financial information included in this report, fairly present in all   materialrespects the financial condition, results of operations and cash   flows of the small business issuer as of, and for,the periods presented in   this report; |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

| 3. | The registrant’s othercertifying officer(s) and I   are responsible for establishing and maintaining disclosure controls and   procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and   internal control over financial reporting (as defined inExchange Act Rules   13a-15(f) and 15d-15(f)) for the small business issuer and have: |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | a. | Designed such disclosure controls and procedures,   or caused such disclosurecontrols and procedures to be designed under our   supervision, to ensure that material information relating to thesmall   business issuer, including its subsidiaries, is made known to us by others   within those entities, particularlyduring the period in which this report is   being prepared; |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | b. | Designed such internal control over financial   reporting, or caused such internalcontrol over financial reporting to be   designed under our supervision, to provide reasonable assurance regarding thereliability of financial reporting and the preparation of financial   statements for external purposes in accordancewith generally accepted   accounting principles; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | c. | Evaluated the effectiveness of   the registrant’s disclosure controls andprocedures and presented in this   report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such   evaluation; and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | d. | Disclosed in this report any change in the   registrant’s internal control overfinancial reporting that occurred during   the registrant’s most recent fiscal quarter (the registrant’s fourth fiscalquarter in the case of an annual report) that has materially affected, or is   reasonably likely to materially affect,the registrant’s internal control   over financial reporting; and |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

| 4. | The registrant’s othercertifying officer(s) and I   have disclosed, based on our most recent evaluation of internal control over   financialreporting, to the registrant’s auditors and the audit committee of   the registrant’s board of directors (or personsperforming the equivalent functions): |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | a. | All significant deficiencies and material   weaknesses in the design or operationof internal control over financial   reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | b. | Any fraud, whether or not material, that involves   management or other employeeswho have a significant role in the registrant’s   internal control over financial reporting. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| *By:* | */s/ Irene Getty*                                       |  |
|-------|---------------------------------------------------------|--|
|       | Irene Getty                                             |  |
|       | Chief Financial Officer   (Principal Financial Officer) |  |
|       | January 23, 2020                                        |  |

----